Mucosal Microbiome in Human Gastric Intestinal Metaplasia and Duodenal Tissue.

• Conditions: Gastric Intestinal Metaplasia; Duodenum; Mucosal Microbiome

• Registration Number: NCT02428426
• Lead Sponsor: Shandong University

Brief Summary

To investigate the mucosal microbiome in human gastric intestinal etaplasia and duodenal tissue.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-09
• Status Verified: 2015-04
• Study First Submitted: 2015-04-23
• Study First Submitted QC: 2015-04-23
• Last Update Submitted: 2015-04-23
• Study First Posted: 2015-04-28
• Last Update Posted: 2015-04-28
• Primary Completion: 2015-07
• Study Completion: 2015-07

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• Patients scheduled for gastroendoscopy examination Aged between 18 and 80 years old

Exclusion Criteria

• Antibiotic, probiotic or prebiotic usage within 2months,gastric inhibitor usage within 1 month Esophageal, gastric or duodenal cancer or other malignancy History of upper GI tract surgery Coagulopathy or bleeding disorders Allergy to fluorescein sodium Pregnant or breast-feeding (for females) Impaired renal function

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The operational taxonomy units in gastric Intestinal Metaplasia and and Duodenal mucosal microbiome	6 months

Trial Locations

Locations (1)

Department of Gastroenterology, Qilu Hospital, Shandong University; 🇨🇳 Jinan, Shandong, China